Completed PHASE2 INTERVENTIONAL 1-arm NCT01588964

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer (IPHC)

Surgery and Intraperitoneal Hyperthermic Chemotherapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer .

Sponsor: Catholic University of the Sacred Heart

Conditions Ovarian Epithelial Cancer Recurrent

Interventions HIPEC

Updated 5 times since 2017 Last updated: Apr 28, 2012 Started: Mar 31, 2005 Primary completion: Oct 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01588964, this PHASE2 trial focuses on Ovarian Epithelial Cancer Recurrent and remains completed. Sponsored by Catholic University of the Sacred Heart, it has been updated 5 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.